Tough Road Lies Ahead For Proposed Biologics Bill
A U.S. Senate committee will consider a compromise version of legislation that would give the U.S. Food and Drug Administration a way to approve generic or follow-on biologic drugs on Wednesday....To view the full article, register now.
Already a subscriber? Click here to view full article